DDD: Summary for SCOLR PHARMA INC - Yahoo! Canada Finance

SCOLR PHARMA INC (AMEX:DDD) Delayed quote data

Last Trade:	0.58 USD
Trade Time:	Feb 9
Change:	0.02 (3.33%)
Prev Close:	0.60
Open:	0.59
Bid:	N/A
Ask:	N/A
1y Target Est:	N/A

Day's Range:	0.50 - 0.61
52wk Range:	0.25 - 0.85
Volume:	76,574
Avg Vol (3m):	50,957.1
Market Cap:	23.84M
P/E (ttm):	N/A
EPS (ttm):	-0.24
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Free Annual Reports

Add DDD to Portfolio

Download Data

HEADLINES

•	SCOLR PHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
	EDGAR Online (Mon, Jan 4)

•	SCOLR PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers
	EDGAR Online (Wed, Dec 16)

•	SCOLR Pharma, Inc. Licenses Dietary Supplements
	PRNewswire (Tue, Dec 1)

•	SCOLR PHARMA, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
	EDGAR Online (Mon, Nov 30)

•	SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards
	PRNewswire (Mon, Nov 30)

•	SCOLR PHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
	EDGAR Online (Wed, Nov 25)

•	SCOLR PHARMA, INC. Financials
	EDGAR Online Financials (Fri, Nov 13)

•	SCOLR PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
	EDGAR Online (Mon, Nov 9)

•	SCOLR PHARMA, INC. Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Fri, Nov 6)

•	SCOLR PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
	EDGAR Online (Tue, Nov 3)

More Headlines for DDD...

BUSINESS SUMMARY

SCOLR Pharma, Inc., a pharmaceutical company, develops and formulates over-the-counter products, prescription drugs, and dietary supplement products that use its patented controlled delivery technology (CDT) technology.

Full Company Profile

Add to Portfolio

Email to a Friend

•

	Sign In [New User? Sign Up]	Finance Home \|Help

SCOLR Pharma Inc. (DDD)